Friday
SESSION 83: MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs; NEW INFORMATION ON TREATMENT OF TANDEM LESIONS, CAROTID ANEURYSMS AND STROKES DURING INTERVENTION
Location: Grand Ballroom East, 3rd Floor
Moderators:Christopher J. Kwolek, MD, MBA / Anne L. Abbott, MD, PhD, FRACP  
SESSION 83 SCHEDULE
12:54 PM - 12:59 PM Current Best Treatment For Strokes Apparent During Or Right After CEA, CAS Or TCAR: Best Diagnostic Modalities And Treatments: Who Should Be Involved And What Skills Are Needed
  Presenter(s):Gert J. de Borst, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
UPDATE ON CAROTID RCTs
1:00 PM - 1:05 PM

Power Point Presentation with Synched Audio
5-Year Results From SPACE 2: CEA Versus Best Medical Treatment (BMT) And CAS Versus BMT For ACS: These Results Support A More Conservative Approach To ACS: What More Is Needed
  Presenter(s):Hans-Henning Eckstein, MD, PhD / Christoph Knappich, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:06 PM - 1:11 PM DEBATE: Update On ACST 2: This RCT Found That CEA And CAS For ACS Had Comparable Adverse Event Rates And Implied That Both Invasive Treatments Were Superior To BMT: Does CEA Prevent Dementia
  Presenter(s):Richard Bulbulia, MA, MD, FRCS / Alison Halliday, MS, FRCS  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:12 PM - 1:17 PM DEBATE: Not So Fast! ACST 2 – Like CREST – Has Flaws That Invalidate Their Conclusions: Invasive Therapies May NOT Be Better Than BMT
  Presenter(s):J. David Spence, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:18 PM - 1:23 PM Update On CREST 2: CEA Versus BMT And CAS Versus BMT For ACS: Recruitment And Findings To Date: Why Not Present The 30-Day And 1 Year Results: If BMT Showed No Difference In Stroke And Death Rates With Those Of CAS Or CEA, Wouldn’t It Remove Justification For Invasive Treatment Of ACS
  Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:24 PM - 1:29 PM Consecutive Monocenter Results With CAS For Asymptomatic Carotid Stenosis (ACS): We Should Not Need A RCT: Why Do We Still Need One
  Presenter(s):Klaus D. Mathias, MD / Anna Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:30 PM - 1:35 PM CEA Versus CAS For High-Grade ACS: RCTs (ACT 1 And CREST) Analyzed By Age And Sex: Are There Important Differences
  Presenter(s):Jon S. Matsumura, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
TANDEM CAROTID LESIONS
1:36 PM - 1:41 PM DEBATE: Tandem Lesions At The Carotid Bifurcation Plus The Common Carotid Or Innominate Arteries: Stroke And Mortality Risks Are Higher Than For Simple Bifurcation Lesions: How Best To Treat: Endo, Open, Staged, Hybrid
  Presenter(s):W. Darrin Clouse, MD / Mark Conrad, MD, MMSc  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:42 PM - 1:47 PM DEBATE: Tandem Carotid Lesions: Treatment Risks Need NOT Be Increased: Based On A Meta-Analysis: How Best To Treat To Minimize Risk
  Presenter(s):Ross Naylor, MD, FRCS  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:48 PM - 1:53 PM Silent Coronary Ischemia As Detected By FFRCT Is Common In Carotid Stenosis Patients: Coronary Revascularization In Such Patients Decreases Mortality: When Should It Be Done – Before Or After Carotid Treatment
  Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:54 PM - 2:02 PM Panel Discussion
END OF SESSION 83
previous next